<p>Mice were repeatedly injected i.p. with 7 mg/kg oxaliplatin (OXA) at days 1, 2, 5 and 6 (28 mg/kg cumulated dose; n = 10). Oxidative stress was evaluated by ROS production using dihydroethidium (A) and DCF-DA (B) tests and NO content (C) by the Griess reaction. Values are the mean ± S.E.M. expressed as percentage of the control (n = 8). *: statistically different (p<0.05) from the mean values in control mice.</p
<p>Representative flow cytometry curves of total intracellular ROS levels (H<sub>2</sub>DCFDA) in (<...
<p>(A)(B)SOD activity did not show change in tx or DL mice during the administration. (C)(D) MDA con...
Recently, the adverse effects of perfluoroalkyl substances (PFASs), have been in the spotlight of se...
<p>Mice were repeatedly injected i.p. with 7 mg/kg oxaliplatin (OXA) at days 1, 2, 5 and 6 (28 mg/kg...
<p>Viability was evaluated both by membrane integrity using neutral red test and mitochondrial metab...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed for 24 h to oxaliplatin (OXA) (50, 100 or 200 µM...
Limited information is available regarding the cellular mechanisms of oxaliplatin-induced painful ne...
<p>(A) Reduced glutathione (GSH). (B) Thiobarbituric acid reactive substances (TBARS). Mice were stu...
<p>Oxidative stress was quantified as malondialdehyde (TBARS) in (A) cortex, (C) liver, (E) spleen, ...
<p>(A) Oxaliplatin treatment significantly inhibited the MHCC97H cells s.c. tumor. (B) GS-treated MH...
<p>Reduced glutathione (GSH), oxidized glutathione (GSSG) and malondialdehyde (MDA) were measured in...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed 24 h to oxaliplatin (OXA) (2–200 µM). Cell viabi...
<p>(A) Superoxide dismutase (SOD). (B) Catalase. Mice were studied 72 h after a single i.p. injectio...
<p>The alteration to oxidative stress levels was assessed following ‘priming’ with <i>W</i>. <i>somn...
<p>Nude mice were implanted subcutaneously with cells into flanks on day 0, then treated with or wit...
<p>Representative flow cytometry curves of total intracellular ROS levels (H<sub>2</sub>DCFDA) in (<...
<p>(A)(B)SOD activity did not show change in tx or DL mice during the administration. (C)(D) MDA con...
Recently, the adverse effects of perfluoroalkyl substances (PFASs), have been in the spotlight of se...
<p>Mice were repeatedly injected i.p. with 7 mg/kg oxaliplatin (OXA) at days 1, 2, 5 and 6 (28 mg/kg...
<p>Viability was evaluated both by membrane integrity using neutral red test and mitochondrial metab...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed for 24 h to oxaliplatin (OXA) (50, 100 or 200 µM...
Limited information is available regarding the cellular mechanisms of oxaliplatin-induced painful ne...
<p>(A) Reduced glutathione (GSH). (B) Thiobarbituric acid reactive substances (TBARS). Mice were stu...
<p>Oxidative stress was quantified as malondialdehyde (TBARS) in (A) cortex, (C) liver, (E) spleen, ...
<p>(A) Oxaliplatin treatment significantly inhibited the MHCC97H cells s.c. tumor. (B) GS-treated MH...
<p>Reduced glutathione (GSH), oxidized glutathione (GSSG) and malondialdehyde (MDA) were measured in...
<p>Cells (2×10<sup>5</sup> cells/well) were exposed 24 h to oxaliplatin (OXA) (2–200 µM). Cell viabi...
<p>(A) Superoxide dismutase (SOD). (B) Catalase. Mice were studied 72 h after a single i.p. injectio...
<p>The alteration to oxidative stress levels was assessed following ‘priming’ with <i>W</i>. <i>somn...
<p>Nude mice were implanted subcutaneously with cells into flanks on day 0, then treated with or wit...
<p>Representative flow cytometry curves of total intracellular ROS levels (H<sub>2</sub>DCFDA) in (<...
<p>(A)(B)SOD activity did not show change in tx or DL mice during the administration. (C)(D) MDA con...
Recently, the adverse effects of perfluoroalkyl substances (PFASs), have been in the spotlight of se...